Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

January 31, 2009

Study Completion Date

June 30, 2010

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

RADIATION

radiation therapy

Trial Locations (19)

15219

Mercy Hospital of Pittsburgh, Pittsburgh

18301

Dale and Frances Hughes Cancer Center, East Stroudsburg

19026

Delaware County Memorial Hospital, Drexel Hill

24541

Danville Regional Medical Center, Danville

33136

University of Miami Sylvester Comprehensive Cancer Center, Miami

44304

Akron City Hospital, Akron

44460

Cancer Care Center, Incorporated, Salem

52001

Wendt Regional Cancer Center of Finley Hospital, Dubuque

53226

Medical College of Wisconsin Cancer Center, Milwaukee

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

54601

Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse

84107

Cottonwood Hospital Medical Center, Murray

84143

LDS Hospital, Salt Lake City

84403

McKay-Dee Hospital Center, Ogden

84604

Utah Valley Regional Medical Center - Provo, Provo

84770

Dixie Regional Medical Center, St. George

94609-3305

CCOP - Bay Area Tumor Institute, Oakland

07740-6395

Monmouth Medical Center, Long Branch

37232-5671

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Radiation Therapy Oncology Group

NETWORK

NCT00016315 - Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter